Fingerprint
Dive into the research topics of 'A phase II trial of vorinostat (suberoylanilide hydroxamic acid) in metastatic breast cancer: A California cancer consortium study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase II trial of vorinostat (suberoylanilide hydroxamic acid) in metastatic breast cancer: A California cancer consortium study
Thehang H. Luu, Robert J. Morgan, Lucille Leong, Dean Lim, Mark McNamara, Jana Portnow, Paul Frankel, David D. Smith, James H. Doroshow, David R Gandara, Ana Aparicio, George Somlo, Carol Wong
Research output: Contribution to journal › Article › peer-review
188
Scopus
citations